Abstract:The increasing mortality rate of pancreatic cancer globally necessitates the urgent identification for novel therapeutic targets. This study investigated the expression, functions, and mechanistic insight of G protein inhibitory subunit 3 (Gαi3) in pancreatic cancer. Bioinformatics analyses reveal that Gαi3 is overexpressed in human pancreatic cancer, correlating with poor prognosis, higher tumor grade, and advanced classification. Elevated Gαi3 levels are also confirmed in human pancreatic cancer tissues and primary/immortalized cancer cells. Gαi3 shRNA or knockout (KO) significantly reduced cell viability, proliferation, cell cycle progression, and mobility in primary/immortalized pancreatic cancer cells. Conversely, Gαi3 overexpression enhanced pancreatic cancer cell growth. RNA-sequencing and bioinformatics analyses of Gαi3-depleted cells indicated Gαi3's role in modulating the Akt-mTOR and PKA-Hippo-YAP pathways. Akt-S6 phosphorylation was decreased in Gαi3-depleted cells, but was increased with Gαi3 overexpression. Additionally, Gαi3 depletion elevated PKA activity and activated the Hippo pathway kinase LATS1/2, leading to YAP/TAZ inactivation, while Gαi3 overexpression exerted the opposite effects. There is an increased binding between Gαi3 promoter and the transcription factor TCF7L2 in pancreatic cancer tissues and cells. Gαi3 expression was significantly decreased following TCF7L2 silencing, but increased with TCF7L2 overexpression. In vivo, intratumoral injection of Gαi3 shRNA-expressing adeno-associated virus significantly inhibited subcutaneous pancreatic cancer xenografts growth in nude mice. A significant growth reduction was also observed in xenografts from Gαi3 knockout pancreatic cancer cells. Akt-mTOR inactivation and increased PKA activity coupled with YAP/TAZ inactivation were also detected in xenograft tumors upon Gαi3 depletion. Furthermore, bioinformatic analysis and multiplex immunohistochemistry (mIHC) staining on pancreatic cancer tissue microarrays showed a reduced proportion of M1-type macrophages and an increase in PD-L1 positive cells in Gαi3-high pancreatic cancer tissues. Collectively, these findings highlight Gαi3's critical role in promoting pancreatic cancer cell growth, potentially through the modulation of the Akt-mTOR and PKA-Hippo-YAP pathways and its influence on the immune landscape.

The critical role of Gαi3 in oral squamous cell carcinoma cell growth

Identification of Gαi3 As a Promising Target for Osteosarcoma Treatment

Identification of Gαi3 As a Novel Molecular Therapeutic Target of Cervical Cancer

Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer

Effects of Insulin-Like Growth Factor Binding Protein 3 on Cell Growth and Tumorigenesis in Oral Squamous Cell Carcinoma

Increased LGALS3BP Promotes Proliferation and Migration of Oral Squamous Cell Carcinoma Via PI3K/AKT Pathway

NCAPG, Mediated by Mir-378A-3p, Regulates Cell Proliferation, Cell Cycle Progression, and Apoptosis of Oral Squamous Cell Carcinoma Through the GSK-3β/β-catenin Signaling.

Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma.

A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc

MiR‐210‐3p‐EphrinA3‐PI3K/AKT Axis Regulates the Progression of Oral Cancer

Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway

Hedgehog/Gli2 signaling triggers cell proliferation and metastasis via EMT and wnt/β-catenin pathways in oral squamous cell carcinoma

Long Non-Coding RNA P4713 Contributes to the Malignant Phenotypes of Oral Squamous Cell Carcinoma by Activating the JAK/STAT3 Pathway.

The LINC00319 binding to STAT3 promotes the cell proliferation, migration, invasion and EMT process in oral squamous cell carcinoma

Identification of G Protein Subunit Alpha I2 As a Promising Therapeutic Target of Hepatocellular Carcinoma

Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma

Stat3 Inhibitor Wp1066 Attenuates Mirna-21 to Suppress Human Oral Squamous Cell Carcinoma Growth in Vitro and in Vivo

MicroRNA-330-3p Regulates the Cell Proliferation and Apoptosis of Oral Squamous Cell Carcinoma

Investigating the Role and Mechanism of Microrna-196A in Oral Squamous Cell Carcinoma by Targeting FOXO1

IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.

The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2